KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Free Cash Flow (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Free Cash Flow for 17 consecutive years, with -$45.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 156.33% to -$45.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$157.6 million, a 154.42% decrease, with the full-year FY2025 number at -$157.6 million, down 154.42% from a year prior.
  • Free Cash Flow was -$45.8 million for Q4 2025 at Bio-Rad Laboratories, down from -$31.7 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $195.7 million in Q3 2021 to a low of -$45.8 million in Q4 2025.
  • A 5-year average of $31.7 million and a median of $34.2 million in 2023 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: soared 1079.77% in 2021, then tumbled 216.22% in 2025.
  • Bio-Rad Laboratories' Free Cash Flow stood at $114.7 million in 2021, then crashed by 60.94% to $44.8 million in 2022, then decreased by 13.52% to $38.7 million in 2023, then surged by 109.87% to $81.3 million in 2024, then tumbled by 156.33% to -$45.8 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Free Cash Flow are -$45.8 million (Q4 2025), -$31.7 million (Q3 2025), and -$45.7 million (Q2 2025).